If approved, drug may be first administered in pill form to treat disease in the world; results of clinical trials of Molnupiravir excited scientists
Pharmaceuticals Merck announced this Monday, 11, that it has requested authorization from the regulatory agency of USA (FDA) for emergency use of the droga antiviral Molnupiravir against a Covid-19. The drug is being studied as an alternative to treat mild and moderate cases of the disease that are at risk of developing into more severe versions of Covid-19, causing hospitalization or death. The research around the drug was done by Emory University in Atlanta, and the administration given during the testing phase was four pills twice a day for five days in a row. If approved, the drug could be the first oral drug to treat the disease. According to preliminary analysis of the studies, administering the drug would reduce the risk of hospitalization caused by the disease by 50%. If the drug is approved by the FDA, the drugmaker’s expectation is that 1.7 million doses will be delivered to the US government for distribution.